Fibromyalgia: An Urgent Need for Harmonized, Global, and Patient-Centric Regulatory Guidance for Developing Medications for the Treatment of Pain and Associated Symptoms

Pain Med. 2019 Oct 1;20(10):2074-2077. doi: 10.1093/pm/pnz077.

Authors

D Merante¹, S Patel²

Affiliations

¹ Independent Global Pharmaceutical Physician/Endocrine and diabetes specialist/currently VP Clinical Development, Clinical Development, Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, UK.
² Independent Global Pharmaceutical Physician/ Currently Spring Grove Medical Practice, Thornbury Road Centre, Isleworth TW7 4HQ, Middlesex, London, UK.

PMID: 30958886
DOI: 10.1093/pm/pnz077

No abstract available

MeSH terms

Catastrophization / psychology
Endpoint Determination
Fibromyalgia / psychology
Fibromyalgia / therapy*
Humans
Legislation, Medical*
Pain / complications
Pain / drug therapy*
Patient-Centered Care / methods*
Treatment Failure
United States
United States Food and Drug Administration